FDA List Of Supplement Formulation Taboos Adds Ephedra-Like Ingredient
This article was originally published in The Tan Sheet
Executive Summary
CFSAN warns seven companies about products marketed as supplements with labeling listing methylsynephrine as a dietary ingredient. The center also warned two of the firms their products contained other ingredients FDA previously began forcing off the market, DMAA and DMBA.
You may also be interested in...
DMAA, Other Stimulants Cast Shadow Over FDA Supplement Regulation – Study
Six workout and weight loss brands contained DMAA and three other stimulants, according to a study in the Journal Clinical Toxicology. Researchers concluded consumers must be informed of risk so they know to check labels for three substances that indicate the presence of the stimulants.
Second Warning, Second Unsafe Ingredient For Total Body Nutrition
FDA's Sept. 28 warning letter to Total Body Nutrition also noted violative claims and labeling for its products marketed with the TBN brand and listed GMP problems. First methylsynephrine in 2016, now DMAA land firm on FDA enforcement radar.
Supplement Industry Stained By Criticism Due Irresponsible Firms
FDA's warnings to industry "about safety have not always been met adequately or even uniformly accepted," says Steve Tave, director of the agency's dietary supplement programs.